Authors
Latest:
Dr. Schilling on Dense Breast Tissue Detection MethodsKathy J. Schilling, MD, a radiologist at Boca Raton Regional Hospital, discusses the importance of additional screening for women with dense breasts.
Latest:
Dr. Albain Discusses Race-Based Breast Cancer Study Within TAILORxKathy S. Albain, MD, director, Breast Clinical Research Program, co-director, Breast Oncology Center, professor of medicine, Stritch School of Medicine, Loyola University Chicago, discusses a race-based study within the TAILORx trial.
Latest:
It Takes a Village, Not a NavigatorPontchartrain Cancer Center was faced with the same dilemma most community-based independents have dealt with: reinvent the practice or join a hospital.
Latest:
Cancer-Related Pain Fraught With Therapeutic and Ethical ComplexitiesAs long-term cancer survival rates continue to surge, an increasing percentage of patients with cancer-related pain are progressing to the chronic pain arena, which necessitates more contemporary treatment approaches to cancer pain management.
Latest:
Adapt Healthcare Skills to Meet Cancer Needs of LGBT CommunityCancer doesn’t discriminate, but that doesn’t mean the healthcare system won’t. This proves to be even more true for the lesbian, gay, bisexual and transgender community.
Latest:
Incorporating PROs Can Improve Patient Care and Outcomes in OncologyKarnofsky Performance Status and ECOG performance status alone leaves a lot to be desired for the practicing oncologist.
Latest:
Dr. Kerrigan on Sequencing Challenges in ALK+ NSCLCKatie Kerrigan, MD, discusses sequencing challenges in the treatment of patients with ALK-positive non–small cell lung cancer.
Latest:
Immunotherapy Combinations Deliver Outcome-Shifting Responses in LymphomaImmunotherapy has become a valuable tool for the treatment of patients with various types of lymphomas because of its ability to specifically target cancer cells, particularly those in blood cancers.
Latest:
Cures Act Moves Step Closer to Adoption With Senate ApprovalThe sweeping, $6.3 billion 21st Century Cures Act, designed to create a 10-year pool of money for precision medicine development and social health initiatives, gained overwhelming Senate approval Wednesday and goes next to President Obama, who has said he will sign the bill.
Latest:
Moving Beyond Standard of Care: Novel Treatments in Gynecologic CancerIn the United States, gynecologic cancers affect nearly 80,000 women annually and are the cause of death in more than 25,000 women.
Latest:
Unmet Needs in the Management of Multiple MyelomaSagar Lonial, MD, provides insight on mechanisms of resistance to CAR T-cell therapies, and the panel shares unmet needs and future directions for the treatment of multiple myeloma.
Latest:
Dr. Uesaka on Gemcitabine vs S-1 in Pancreatic CancerKatsuhiko Uesaka, MD, PhD, from the Shizuoka Cancer Center Hospital in Japan, discusses the JASPAC-01 study that compared gemcitabine to S-1 in Asian patients with resected pancreatic cancer.
Latest:
Dr Parikh on the Impact of the ADAURA and ALINA Trials on Early-Stage NSCLC ManagementKaushal Parikh, MBBS, discusses how data from the ADAURA and ALINA trials have advanced the management of early-stage non–small cell lung cancer.
Latest:
Dr. Patel Discusses the Cancer Drug Coverage Parity ActKavita Patel, MD, MS, policy analyst, Brookings Institution, discusses the Cancer Drug Coverage Parity Act.
Latest:
Dr. Ramchandran on Considerations for Palliative Care in Thoracic CancersKavitha Ramchandran, MD, discusses considerations as patients with thoracic malignancies enter palliative care.
Latest:
Dr. Nagawaka Discusses Findings of the RELAY Trial in EGFR+ NSCLCKazuhiko Nakagawa, MD, PhD, Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan, discusses findings of the RELAY trial in EGFR-positive non–small cell lung cancer.
Latest:
Dr. Begna on Recent Advancements in MPNsKebede H. Begna, MD, assistant professor of Medicine, Mayo Clinic, discusses some of the recent advancements in the field of myeloproliferative neoplasms (MPNs).
Latest:
Dr. Gogineni on the Efficacy of CDK4/6 Inhibitors Plus Endocrine Therapy in HR+, HER2- Early Breast CancerKeerthi Gogineni, MD, MSHP, discusses the efficacy of CDK4/6 inhibitors plus endocrine therapy in patients with hormone receptor–positive, HER2-negative early breast cancer.
Latest:
Dr. Gogineni on Implications of the APT Trial in HER2+ Breast CancerKeerthi Gogineni, MD, MSHP, discusses the clinical implications of the phase II APT trial in HER2-positive breast cancer.
Latest:
Dr. Muro Discusses Safety Data from Asian XELIRI Project in CRCKei Muro, MD, Aichi Cancer Center Hospital, discusses the findings of Asian XELIRI project (AXEPT) in colorectal cancer (CRC).
Latest:
Dr. Bible on Impact of Lenvatinib on Treatment Landscape of DTCKeith C. Bible, MD, PhD, medical oncologist, Mayo Clinic, discusses the impact that lenvatinib (Lenvima) has had on the treatment landscape of differentiated thyroid cancer.
Latest:
Dr. Kerr on Misconceptions With Molecular Profiling in Lung CancerKeith Kerr, BSc, MB, ChB, consultant pathologist, University of Aberdeen, Aberdeen, Scotland, discusses common misconceptions with molecular profiling in lung cancer.
Latest:
Dr. Unger on Utilizing a Multidisciplinary Team in Gastroesophageal CancerKeith R. Unger, MD, discusses utilizing a multidisciplinary team to treat patients with gastroesophageal cancer.
